BFC Planning’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.73K Hold
1,000
– – ﹤0.01% 3044
2026
Q2
$1.99K Buy
+1,000
New +$1.44K ﹤0.01% 2991
2026
Q1
– Sell
-9
Closed -$22 – 3162
2025
Q4
$22 Sell
9
-126
-93% -$345 ﹤0.01% 3197
2025
Q3
$385 Hold
135
– – ﹤0.01% 2777
2025
Q2
$509 Buy
+135
New +$531 ﹤0.01% 2543

Other funds holding HCAT

BFC Planning's HCAT Position: Q3 2026 in Review

BFC Planning held its Health Catalyst (HCAT) position steady in Q3 2026 at 1,000 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

BFC Planning first reported a position in HCAT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.99K in Q2 2026. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • BFC Planning held 1,000 shares of Health Catalyst worth $1.73K as of Q3 2026.
  • BFC Planning left its Health Catalyst share count unchanged in Q3 2026.
  • Health Catalyst made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3044 holding.
  • BFC Planning first reported a position in Health Catalyst in Q2 2025 and has held it in 5 quarters since.
  • BFC Planning's Health Catalyst position peaked at $1.99K in Q2 2026.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.